申请人:UNIV INDIANA RES & TECH CORP
公开号:WO2012173677A2
公开(公告)日:2012-12-20
The invention described herein pertains to anticancer therapeutic agents that exhibit preferential cytotoxicity to malignant cells that express a cancer specific isoform of proliferating cell nuclear antigen (caPCNA) compared to cytotoxicity to comparable non- malignant cells, pharmaceutical compositions comprising the agents, and their use in cancer therapy.